Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|---|
Gross Sales | 8,046 | 7,011 | 7,283 | 6,871.05 | 5,023.28 |
Excise Duty | 775 | 640 | 664 | 785.54 | 517.18 |
Net Sales | 7,271 | 6,371 | 6,619 | 6,085.51 | 4,506.1 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 16 | 11 | 0 | 0.77 | 0.7 |
Total Income | 7,287 | 6,382 | 6,619 | 6,086.28 | 4,506.8 |
Total Expenditure | 6,271 | 5,398 | 5,529 | 4,365.4 | 3,524.57 |
PBIDT | 1,016 | 984 | 1,090 | 1,720.88 | 982.23 |
Interest | 275 | 211 | 168 | 102.33 | 86.37 |
PBDT | 741 | 773 | 922 | 1,618.55 | 895.86 |
Depreciation | 434 | 378 | 310 | 246.4 | 231.31 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | -5 | 0 | 49 | 163.8 | 106.23 |
Deferred Tax | -19 | -21 | 18 | 22.45 | 23.1 |
Reported Profit After Tax | 331 | 416 | 545 | 1,185.9 | 535.22 |
Minority Interest After NP | 0 | 0 | 0 | 0.23 | 11.75 |
Net Profit after Minority Interest | 331 | 416 | 545 | 1,185.67 | 523.47 |
Extra-ordinary Items | 2 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 329 | 416 | 545 | 1,185.67 | 523.47 |
EPS (Unit Curr.) | 9.13 | 11.49 | 15.04 | 32.71 | 30.04 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 20 | 20 | 50 | 70 | 60 |
Equity | 181 | 181 | 181 | 181.25 | 87.12 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 13.97 | 15.44 | 16.46 | 28.27 | 21.79 |
PBDTM(%) | 10.19 | 12.13 | 13.92 | 26.59 | 19.88 |
PATM(%) | 4.55 | 6.52 | 8.23 | 19.48 | 11.87 |
Pharma's volume increased significantly during the pandemic and has now stabilised since FY24.
Here are some of the stocks that may see significant price movement today: Tata Motors, Asian Paints, Divi’s Laboratories, etc.
Here are some of the stocks that may see significant price movement today: Mazagon Dock Shipbuilders, Krsnaa Diagnostics, Dr Reddy's, etc.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.